On the Record · Idexx Laboratories

Idexx Laboratories acquisitions, on the record

The businesses Idexx Laboratories bought and sold, as its annual reports describe them, with the cash it reported paying for acquisitions each year and every deal filing since 2016.

Deals its annual reports describe

Business	Deal	When	Value
a privately owned software and data platform business based in the U.S. Word for word“On February 1, 2024, we acquired the assets of a privately owned software and data platform business based in the U.S. that extends our practice management systems cloud-native workflow and delivers strategic data solutions to our customers and their clients for approximately $77 million in cash, and also agreed to make contingent payments of up to $30 million during the subsequent three years, based on the achievement of certain goals.” 10-K for 2023	acquisition	February 1, 2024	approximately $77 million in cash
an international water testing company located in Canada Word for word“During the third quarter of 2022, we acquired the assets of an international water testing company located in Canada for approximately $ 12.8 million in cash, including a holdback of approximately $ 1.3 million, which was paid in the fourth quarter of 2023.” 10-K for 2023	acquisition	During the third quarter of 2022	approximately $ 12.8 million in cash
a reference laboratory located in Finland Word for word“During the fourth quarter of 2021, we acquired the shares of a reference laboratory located in Finland for approximately $ 13.4 million in cash, including a holdback of approximately $ 1.4 million , which was paid in the first quarter of 2023.” 10-K for 2023	acquisition	During the fourth quarter of 2021	approximately $ 13.4 million in cash
the remaining 5 % interest of our sole foreign joint venture operation Word for word“During the fourth quarter of 2021, we acquired the remaining 5 % interest of our sole foreign joint venture operation for approximately $ 1.0 million.” 10-K for 2023	acquisition	During the fourth quarter of 2021	approximately $ 1.0 million
a teleradiology business Word for word“During the third quarter of 2021, we acquired the assets of a teleradiology business for approximately $ 5.4 million, including a contingent payment of $ 0.3 million.” 10-K for 2023	acquisition	During the third quarter of 2021	approximately $ 5.4 million
the ezyVet cloud-based veterinary software businesses, ezyVet US, Inc., and the Vet Radar business assets Word for word“During the second quarter of 2021, we acquired the assets of the ezyVet cloud-based veterinary software businesses and the shares of ezyVet US, Inc., as well as the Vet Radar business assets, for approximately $ 157.2 million, including an estimated contingent payment of $ 5.0 million.” 10-K for 2023	acquisition	During the second quarter of 2021	approximately $ 157.2 million
a reference laboratory located in Switzerland Word for word“During the first quarter of 2021, we acquired the shares of a reference laboratory located in Switzerland for approximately $ 5.5 million in cash, including holdback and contingent payments of approximately $ 1.1 million.” 10-K for 2023	acquisition	During the first quarter of 2021	approximately $ 5.5 million in cash
privately-owned software and data platform business based in the U.S. Word for word“During the first quarter of 2024, we acquired the assets of a privately-owned software and data platform business based in the U.S. that extended our practice management system cloud-native workflow and delivers strategic data solutions to our customers and their clients, for approximately $ 81.1 million, including an estimated contingent payment of $ 4.4 million.” 10-K for 2024	agreed acquisition	During the first quarter of 2024	approximately $ 81.1 million, including an estimated contingent payment of $ 4.4 million
international water testing company located in Canada Word for word“During the third quarter of 2022, we acquired the assets of an international water testing company located in Canada for approximately $ 12.8 million in cash, including a holdback of approximately $ 1.3 million, which was paid in the fourth quarter of 2023.” 10-K for 2024	acquisition	During the third quarter of 2022	approximately $ 12.8 million in cash, including a holdback of approximately $ 1.3 million

As filedReported in the company's financial data (XBRL), each linked to its filing
Fiscal year ended	Cash paid for acquisitions (net of cash acquired)	Goodwill from acquisitions
2016-12-31	$2 million	$1.7 million
2017-12-31	$14.6 million	$13.5 million
2018-12-31	$22.5 million	$20.3 million
2019-12-31	$50.3 million	$24.8 million
2020-12-31	$1.5 million	$220,000
2021-12-31	$173.4 million	$120.3 million
2022-12-31	$11.5 million	$8.5 million
2023-12-31	$0	$0
2024-12-31	$76.7 million	$45.8 million
2025-12-31	$0	—

Deal filings since 2016

2025-11-13 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2024-11-06 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2022-10-21 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2021-12-09 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2020-04-16 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2020-03-27 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2019-03-15 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement

Read from Idexx Laboratories’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2026-02-20. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.